RVPH

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Alert me on RVPH

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

After each filing

No purchase or sale on this ticker by a member of Congress or an insider yet.

Filings for RVPH

21 held · newest 521 held · newest 2

Loading the filings.

See all 21 filings for RVPH

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

No signal for this ticker yet. A signal is written when insider buying here scores one dot or more.

Stakes

Jun 30, 2026 Schedule 13G, amended

Barclays PLC: 0%, 20 shares

Jun 30, 2026 Schedule 13G, amended

Integrated Core Strategies (US) LLC: 8.2%, 1,072,690 shares

Jun 30, 2026 Schedule 13G, amended

UBS Group AG: 0%, 0 shares

Mar 31, 2026 Schedule 13G, amended

CVI Investments, Inc.: 4.9%, 672,811 shares

Mar 31, 2026 Schedule 13G

Barclays PLC: 6%, 763,579 shares

Mar 31, 2026 Schedule 13G

UBS Group AG: 5.8%, 746,095 shares

Mar 23, 2026 Schedule 13G

Integrated Core Strategies (US) LLC: 6.2%, 793,952 shares

Mar 18, 2026 Schedule 13G

CVI Investments, Inc.: 5.2%, 666,667 shares

Mar 20, 2026 Schedule 13D, amended

Parag Saxena: 2.8%, 363,280 shares

Dec 31, 2025 Schedule 13G, amended

683 CAPITAL MANAGEMENT, LLC: 3%, 3,492,500 shares

Dec 31, 2025 Schedule 13G, amended

Integrated Core Strategies (US) LLC: 2.8%, 3,254,631 shares

Dec 18, 2025 Schedule 13D, amended

Parag Saxena: 5.2%, 6,268,006 shares

Sep 22, 2025 Schedule 13G

683 CAPITAL MANAGEMENT, LLC: 5.4%, 5,435,000 shares

Sep 22, 2025 Schedule 13D, amended

Bhat Laxminarayan: 3.8%, 3,680,874 shares

Sep 22, 2025 Schedule 13D, amended

Parag Saxena: 6.2%, 6,259,806 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.